Same Indication

Ipilimumab vs Trazodone

Ipilimumab vs Trazodone: Overview

This comparison examines the pharmacological differences between Ipilimumab and Trazodone.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Trazodone: Serotonin antagonist and reuptake inhibitor (SARI).

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Trazodone — 5-9 hours.

Chemical Properties

Molecular Formula: Trazodone — C19H22ClN5O.

Molecular Weight: Trazodone — 371.8640 g/mol.

Type: Ipilimumab — Antibody; Trazodone — Small molecule.